← Eichor
Study identifier: NCT06127602 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The REACTplusNMES Trial: A Double-blinded RCT

Condition: Stroke, Ischemic · Stroke Hemorrhagic · Stroke, Cerebrovascular  ·  Sponsor: University of Illinois at Chicago

PhaseNA
Planned participants46
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The aim of this study is to compare the effectiveness of 6-weeks of reactive balance training (REACT) with and without neuromuscular electrical stimulation (NMES) to paretic lower limb muscles on biomechanical, clinical, neuromuscular and neuroplastic outcomes of reactive balance control. This project is a Phase-I study and incorporates a double-blinded, randomized controlled trial design. Methods: Forty-six individuals with chronic stroke will be recruited and screened for determining their eligibility for the study. Once enrolled, they will be randomized into either of the two groups: intervention group (23 participants) and control group (23 participants). Both groups will undergo series of pre-training assessments which includes a postural disturbance in the form of a slip- or trip-like perturbations and walking tests in laboratory environment. After the pre-training assessment, individuals will undergo 6-weeks of training (2 hour per session, 2 sessions per week). The intervention group will receive NMES with the REACT training and the control group will receive ShamNMES. NMES will be applied to the different muscle groups of the paretic lower limb using an advanced software which is able to synchronize muscle activation with the time of perturbation onset and according to the phases of gait. After training, both groups will again be tested on all the assessments performed pre training. This study will help us understand the immediate therapeutic and mechanistic effect…

This description comes directly from the study's public registry record.

Talk to the study team

Rudri Purohit, MS  ·  312-413-9772  ·  rpuroh2@uic.edu

Swaranka Deshmukh, MS  ·  312-355-3988  ·  sdeshm9@uic.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Illinois at ChicagoChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06127602